TP53 and acute kidney injury: Given the well-described beneficial effects of p53-deficient mice in several models of AKI and even renal transplantation employing small interfering RNA (siRNA) that targets p53, the protection might result either from resistance to ferroptosis (e.g., in the siRNA experiments) or from an overlapping conventional knockout that might affect flanking genes in the genetic models49–51.